Envoy Medical expands board to seven, adds former Boston Scientific M&A veteran McKhann

Filed April 21, 2026 · Period ending April 15, 2026 · ~1 min read

Key Changes

• medium

  Charles S. McKhann appointed as Class I director and Compensation Committee member, expanding board from six to seven members effective April 15, 2026.

  Item 5.02 verify on EDGAR →
• medium

  McKhann led two medical device companies (Silk Road Medical and Apollo Endosurgery) through successful acquisitions by Boston Scientific, bringing M&A and exit experience to the board.

  Item 5.02 verify on EDGAR →
• low

  New director granted stock options for 100,000 shares at $0.72 exercise price, vesting monthly over 36 months, aligning interests with shareholders.

  Item 5.02 verify on EDGAR →